Submissions of abstracts for the upcoming Annual Medication Management Conference Shifa

2024: AMMC-Shifa is now open. All abstracts must present original research. The abstracts reporting data pending will not be accepted. Submission implies that the material has not previously been presented or published elsewhere before presentation at the Annual Medication Management Conference Shifa 2024: AMMC-Shifa. Please read the abstract guidelines below carefully before submitting.

Theme: “Pharmacists: Meeting global health needs”

The Themes for abstracts should be: Safe, Cost-Efficient and Effective:

• Medication Management & Use in healthcare organization
• Storage and distribution of medicines
• Appropriateness Review of Prescriptions and Dispensing
• Collaborative drug therapy management
• Medication safety
• Prescribing & Transcribing
• Patient and Family Education
• Medicine Administration
• Monitoring of Therapy and Medication Use

List of Track:

Your abstract could be submitted under one of the official tracks for the conference:

• Social and Administrative Pharmacy Services
• Pharmaceutical Public Health
• Clinical Pharmacy services
• Pharmacy informatics
• Pharmaceutical Regulations
• Pharmaceutical Marketing
• Pharmacy Education

Abstracts accepted for session types:

• Poster Presentation
• Oral Presentation

Abstract Format:

Abstracts should be organized as follows:

Abstract title and affiliations: (They will not count as part of the 350 words limit). Titles of more than 25 words (110 characters and spaces) will be truncated. You must add at least 1 author and no more than 8. You must have 2 presenting authors for this submission.

Authors: (mandatory information)

• First name
• Last name
• Institute of each author
• Country
• Role: presenting author’s name, email, and designation.
• Corresponding Author

Background:

State the study question/hypothesis, and rationale, or describe the challenge addressed by the research.

Aim/objectives:

State either the overall study goal or objectives planned for the research.

Design/Methods:

Describe the study design, setting, desired outcomes, procedures, and techniques used to collect and analyze information. Include a description of the appropriate statistical analysis.

Results:

Present important/significant specific findings to date.

Conclusions:

Describe the implications of the results presented and summarize key recommendations. Explain specific findings on how the research addressed the study question or challenge.

Tables/Figures (Optional):

Authors may submit only one table or one figure per abstract. If more than one table or figure is submitted, one of them will be selected.

• A sample abstract is available on the conference link for your reference.

Abstract body:

• The abstract text should not exceed 350 words. Abstracts of more than 350 words will be truncated.
• Please note that abstract titles, affiliations, and references will not be counted as part of the 350 words.
• Abstracts can be submitted in English only. Abstracts submitted in other languages will not be considered. No simultaneous interpretation will be provided at the conference.
• Authors are responsible for proofreading and submitting an abstract without errors, as they will be reproduced in the form they were submitted. No changes will be accepted after the submission.

Submission:

• Abstracts must be sent through an e-mail as an attachment (on sample template) to abstract-ammc@shifa.com.pk
• Fax or hard copy will not be accepted.
• Online submission will remain open till 10th August 2024.
• No further submissions will be accepted after the deadline.
• The corresponding author will receive an email confirming that the submitted abstract has been
• Contact abstract-ammc@shifa.com.pk if you do not receive the confirmation.
• Please do not submit an abstract if none of the authors intends to present it virtually or physically, in the event that it is accepted.

Reviewing:

• All submitted abstracts will be sent for peer review by a panel of national and international experts in the field of Pharmacy Practice.
• Each abstract will be reviewed and scored by at least three reviewers to determine which abstracts are accepted.

Notification:

• Corresponding/presenting authors will be notified of acceptance or non-acceptance of their abstracts.
• Upon notification, corresponding/presenting authors will have to create and submit a printed poster at the conference day.
• If your abstract has been allocated to a specific session, please note that it will not be possible to change the date, time, or type of session.
• A co-author or colleague can present on the initial presenter’s behalf if they are not available on the assigned date and time.
• Abstracts that are not accepted cannot be reconsidered for review or presentation at the conference.

Attendance and registration:

• All delegates registered for the conference can attend any abstract session of the core program.

All abstract presenters must register for the conference.